Company: BLCO
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013244
Chunk: 0

Company: Bausch & Lomb Corp
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 0
---
TABLE OF CONTENTS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )

| ☑ Filed by the Registrant |     | ☐Filed by a Party other than the Registrant |

Check the appropriate box:

| ☐ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(E)(2)) |

| ☑ | Definitive Proxy Statement |

| ☐ | Definitive Additional Materials |

| ☐ | Soliciting Material under §240.14a-12 |

Bausch + Lomb Corporation (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):

| ☑ | No fee required. |

| ☐ | Fee paid previously with preliminary materials. |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

TABLE OF CONTENTS TABLE OF CONTENTS

TABLE OF CONTENTS

Message from the Chairman of the Board and Chief Executive Officer

| April 10, 2025                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 Dear Shareholders:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
 2024 was defined by a relentless focus on selling and operational excellence, with impressive results that support our strategy. We delivered 16 percent reported revenue growth and 17 percent constant currency revenue growth(1)for the full year thanks to seamless execution of new product launches and strengthening leadership in key categories including dry eye. We also significantly enhanced R&D capabilities and reloaded our pipeline, positioning the company for success in the near- and long-term. Innovation is once again core to who we are. 
 I encourage you to learn more about our 2024 performance by visiting the Investors section ofwww.bausch.com, and to attend Bausch + Lomb’s Annual Meeting of Shareholders on Wednesday, May 21, 2025, at 10:30 a.m. (Eastern Daylight Time). We will once again conduct the meeting in an exclusively virtual format via live webcast, which we believe will facilitate broader shareholder attendance and participation.                                                                                                                                           
 Details on the meeting,